These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14991464)

  • 1. Pentoxyphylline and propentophylline are inhibitors of TNF-alpha release in monocytes activated by advanced glycation endproducts.
    Meiners I; Hauschildt S; Nieber K; Münch G
    J Neural Transm (Vienna); 2004 Mar; 111(3):441-7. PubMed ID: 14991464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of plant-derived polyphenols on TNF-alpha and nitric oxide production induced by advanced glycation endproducts.
    Chandler D; Woldu A; Rahmadi A; Shanmugam K; Steiner N; Wright E; Benavente-García O; Schulz O; Castillo J; Münch G
    Mol Nutr Food Res; 2010 Jul; 54 Suppl 2():S141-50. PubMed ID: 20540146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of TNF alpha production inhibitors BRL 61063 and pentoxifylline on the response of rats to poly I:C.
    Kaplan JM; Herzyk DJ; Ruggieri EV; Bartus JO; Esser KM; Bugelski PJ
    Toxicology; 1995 Jan; 95(1-3):187-96. PubMed ID: 7825185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.
    Semmler J; Gebert U; Eisenhut T; Moeller J; Schönharting MM; Alléra A; Endres S
    Immunology; 1993 Apr; 78(4):520-5. PubMed ID: 8388363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress.
    Loske C; Neumann A; Cunningham AM; Nichol K; Schinzel R; Riederer P; Münch G
    J Neural Transm (Vienna); 1998; 105(8-9):1005-15. PubMed ID: 9869332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted xanthines, pteridinediones, and related compounds as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha.
    Cottam HB; Shih H; Tehrani LR; Wasson DB; Carson DA
    J Med Chem; 1996 Jan; 39(1):2-9. PubMed ID: 8568809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages.
    Marques LJ; Zheng L; Poulakis N; Guzman J; Costabel U
    Am J Respir Crit Care Med; 1999 Feb; 159(2):508-11. PubMed ID: 9927365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
    Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
    Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGEs mediated expression and secretion of TNF alpha in rat retinal microglia.
    Wang AL; Yu AC; He QH; Zhu X; Tso MO
    Exp Eye Res; 2007 May; 84(5):905-13. PubMed ID: 17359975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts.
    Abordo EA; Thornalley PJ
    Immunol Lett; 1997 Aug; 58(3):139-47. PubMed ID: 9293394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array.
    Berbaum K; Shanmugam K; Stuchbury G; Wiede F; Körner H; Münch G
    Cytokine; 2008 Mar; 41(3):198-203. PubMed ID: 18166486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AGEs-RAGE mediated up-regulation of connexin43 in activated human microglial CHME-5 cells.
    Shaikh SB; Uy B; Perera A; Nicholson LF
    Neurochem Int; 2012 May; 60(6):640-51. PubMed ID: 22417726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
    Rashid G; Korzets Z; Bernheim J
    Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proglycation effect of caffeic acid leads to the elevation of oxidative stress and inflammation in monocytes, macrophages and vascular endothelial cells.
    Wu CH; Huang HW; Lin JA; Huang SM; Yen GC
    J Nutr Biochem; 2011 Jun; 22(6):585-94. PubMed ID: 20951562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-tocopherol decreases tumor necrosis factor-alpha mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase.
    Devaraj S; Jialal I
    Free Radic Biol Med; 2005 May; 38(9):1212-20. PubMed ID: 15808419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming of P-glycoprotein mediated vincristine resistance of L1210/VCR mouse leukemic cells could be induced by pentoxifyline but not by theophylline and caffeine.
    Stefanková Z; Barancík M; Breier A
    Neoplasma; 1996; 43(1):11-5. PubMed ID: 8843953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.
    Schandené L; Vandenbussche P; Crusiaux A; Alègre ML; Abramowicz D; Dupont E; Content J; Goldman M
    Immunology; 1992 May; 76(1):30-4. PubMed ID: 1385797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
    Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
    J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
    Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.